CD16 Antikörper (AA 31-215) (FITC)
-
- Target Alle CD16 Antikörper anzeigen
- CD16
-
Bindungsspezifität
- AA 31-215
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CD16 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Maus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Mouse Low affinity immunoglobulin gamma Fc region receptor III protein (31-215AA)
- Isotyp
- IgG
- Top Product
- Discover our top product CD16 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CD16
- Andere Bezeichnung
- Fcgr3 (CD16 Produkte)
- Synonyme
- Fcgr3 antikoerper, Fcgr3a antikoerper, CD16 antikoerper, FCGR3 antikoerper, FCGR3@ antikoerper, CD16b antikoerper, FCG3 antikoerper, FCR-10 antikoerper, FCRIII antikoerper, FCRIIIb antikoerper, FcRIII antikoerper, Fc fragment of IgG, low affinity IIa, receptor antikoerper, Fc fragment of IgG, low affinity IIIa, receptor (CD16a) antikoerper, Fc fragment of IgG receptor IIIb antikoerper, Fc fragment of IgG receptor IIIa antikoerper, Fc receptor, IgG, low affinity III antikoerper, Fc-gamma RIII antikoerper, Fcgr2a antikoerper, FCGR3A antikoerper, FCGR3B antikoerper, Fcgr3 antikoerper, FCGR3 antikoerper
- Hintergrund
-
Background: Receptor for the Fc region of complexed immunoglobulins gamma. Low affinity receptor.
Aliases: Fcgr3Low affinity immunoglobulin gamma Fc region receptor III antibody, IgG Fc receptor III antibody, Fc-gamma RIII antibody, FcRIII antibody, CD antigen CD16 antibody
- UniProt
- P08508
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-